(Q51459007)

5 April 2018

title

Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model. (English)

1 reference

5 April 2018

0 references

White CM

1

1 reference

5 April 2018

Xie J

series ordinal

2

1 reference

5 April 2018

Chow MS

series ordinal

3

1 reference

5 April 2018

Kluger J

series ordinal

4

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

5 April 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Pharmacotherapy

1 reference

5 April 2018

volume

19

1 reference

5 April 2018

issue

5

1 reference

5 April 2018

page(s)

635-640

1 reference

5 April 2018

Torsade de pointes. Mechanisms and management.

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Magnesium ions in cardiac function. Regulator of ion channels and second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Is hypomagnesemia arrhythmogenic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Torsades de pointes and early afterdepolarizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Experimental models of torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Evolving role of sotalol in the management of ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

Differential effects of D-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.8.635.31528

10.1592/PHCO.19.8.635.31528

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018